| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2018 | Sep 19, 2018 | Duliege Anne-Marie EVP Chief Medical Officer | Sell | Rigel Pharmaceuticals Inc | RIGL | $3.5 | $535,500 | -0 |
| Sep 04, 2018 | Sep 06, 2018 | Duliege Anne-Marie EVP Chief Medical Officer | Sell | Rigel Pharmaceuticals Inc | RIGL | $3.51 | $57,861 | -0 |
| Jul 02, 2018 | Jul 05, 2018 | Duliege Anne-Marie EVP Chief Medical Officer | Sell | Rigel Pharmaceuticals Inc | RIGL | $2.79 | $13,932 | -0 |
| Apr 20, 2018 | Apr 25, 2018 | Duliege Anne-Marie EVP Chief Medical Officer | Sell | Rigel Pharmaceuticals Inc | RIGL | $4.11 | $20,550 | -0 |
| Jul 05, 2017 | Jul 07, 2017 | Duliege Anne-Marie Chief Medical Officer | Sell | Rigel Pharmaceuticals Inc | RIGL | $2.69 | $13,427 | -0 |
| Jan 03, 2017 | Jan 13, 2017 | Duliege Anne-Marie Chief Medical Officer | Sell | Rigel Pharmaceuticals Inc | RIGL | $2.41 | $12,028 | -50.00% |
| Nov 18, 2014 | Nov 21, 2014 | Duliege Anne-Marie EVP Chief of Strategic Dev. | Sell | Chemocentryx, Inc. | CCXI | $4.71 | $23,432 | -0 |